Ethical Objections to Commercial Farming and Consumption of Genetically Modified Foods in Kenya by Makokha, K & Kyalo, W
 
 
Ethical Objections to Commercial Farming and 
Consumption of Genetically Modified Foods in Kenya 
 
Kibaba Makokha 
Department Of Philosophy and Religious Studies 













Thought and Practice: A Journal of the Philosophical Association of Kenya (PAK) 










 Food insecurity remains one of the most pressing problems of Third World countries. 
The causes of this predicament are varied, ranging from drought, inadequate farming 
methods, poverty, among others. The responses to famine, whenever it strikes in 
many of these countries, have also been varied, with the most popular one being 
appeals for food aid from wealthy individuals, corprate bodies and the international 
community. However, these initiatives have not been sustainable. The need for a 
permanent solution has attracted varied opinions. O the one hand, some stakeholders 
take the view that the solution lies in genetically modified foods. On the other, some 
of the stakeholders are either opposed to such foods, or are cautious about them, citing 
potential and/or real risks associated with them. This article is premised on the view 
that technological innovations often raise ethical oncerns and even dilemmas that 
ought to be surmounted in order to enhance public acceptability. In this regard, the 
article reflects on the ethical objections against GM technology in general, and, in 
particular, the process leading to the enactment of the biosafety law in Kenya. 
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The ugly scenes of individuals and communities ravaged by starvation are often 
brought into our living rooms on our television screens. The predictable response to 
this state of affairs is for individuals, corporate organizations and even Government 
appealing for food and other material donations. The most recent severe case of 
famine in Kenya was in 2011, when about 3 million peo le were faced with starvation 
in Northern Kenya. Predictably, there was an appeal by the Government and the local 
communities for assistance. In response, the Safaricom Foundation, Kenya 
Commercial Bank (KCB), Media Owners Association (MOA), and the Kenya Red 
Cross Society (KRCS) launched the Kenyans for Kenya I itiative. The main objective 
of the initiative was to mobilize corporate organizat ons and the public in general to 
raise 500 million shillings to alleviate the famine. This kind of response, though 
noble, is not sustainable, as it does not address th  root cause of food insecurity. 
 
In the light of the observations above, opinion is divided regarding the permanent 
solution to the problem of food insecurity. One shade of opinion routes for 
widespread adoption of commercial farming and consumption of genetically modified 
foods, which are products of genetically modified (GM) technology. To this group, 
GM technology is the panacea to the perennial problem of food shortage in the third 
world. To them, GM technology will not only assure increased food production, but 
also its quality. Over the years this opinion has received substantial support, and under 
the auspices of the UN Convention on Biological Diversity (SCBD1995), many 
member countries have been trying to put in place the necessary legal and regulatory 
framework to guide implementation. Kenya is one such country: it enacted the 
Biosafety Act in 2009, and has since put in place th necessary guidelines to 
operationalize it. 
 
 The contrary shade of opinion is either opposed to or has misgivings about the 
introduction, commercial farming and consumption of genetically modified foods. 
This group cites actual or potential uncertainties and risks that GM technology 
portends to human health and the natural environment. 
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Both shades of opinion are supported by credible res arch. In Kenya, even with the 
necessary legal framework in place, the importation and farming of GM foods remain 
banned. Furthermore, as will be illustrated in this article, the Kenyan government 
fears public backlash if it goes ahead to implement the Biosafety Act. 
 
It is in the light of these controversies and challenges that this article seeks to 
interrogate the ethical objections to the GM technology itself, the processes leading to 
the enactment of the Biosafety Act in Kenya and thesubsequent reluctance to 
implement it. The article argues that GM technology raises legitimate and outstanding 
ethical concerns, even dilemmas, that ought to be addressed to protect consumers’ 
individual and collective liberty of autonomy and self-determination. The article 
evaluates the ethical implications of the production, consumption and commercial 
farming of genetically modified organisms (GMOs) in Kenya. It is partly based on the 
findings of a research project carried out by one of the co-authors on “Stakeholders’ 
Public Participation in Policy Formulation and their Perception towards Genetically 
Modified Foods in Nairobi, Kenya”. 
 
The GMO Debate in Perspective 
A genetically modified organism is one into which one or more genes have been 
introduced into its genetic material from another organism (Barret and Flora 2000; 
Juma and Mugabe 1994). The resultant organism is called transgenic animal, plant or 
organism with genetically enhanced capacities. Genetic modification technology is a 
subset of biotechnology known as genetic engineering which involves the 
manipulation of the germ cell, that is, reproductive cell, to improve the genetic code 
of an organism (Kyalo 2008). The United Nations Convention on Biological Diversity 
defines biotechnology as the use of living systems and organisms to develop or make 
products, or any technological application that uses biological systems, living 
organism or derivatives thereof to make or modify products or processes for specific 
uses (SCBD 2000). 
 
The desire to improve the quality of organisms, both human and non-human, through 
technology has a long and controversial history. People have sought to fulfil it 
through different methods including selective breeding, and the infamous eugenic 
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program which involved the use of such methods as sterilization and cross breeding 
(Boss 1999). It was however the discovery of the molecular structure of the deoxy 
ribonucleic acid (DNA) by James Watson and Francis Cr ck in the 1950’s that marked 
a major turning point in the field of biotechnology. This discovery ushered in the era 
of genetic engineering (Boss 1999, 173). With these br akthroughs, by the 
1980’s,scientists were already genetically modifying organisms ( food) by introducing 
genetic material from one organism into another, for example, taking material from 
fish, bacteria, viruses and insects and adding them into fruits, grains and vegetables to 
enhance their durability and quality (Kyalo 2008). With these developments, the era 
of GMO’s was here with us. Through genetic engineering, scientists are able to 
pinpoint the individual gene which produces a desired outcome, extract it, copy it and 
insert it into another organism (Barrett and Flora 2000). 
 
The revolution brought about by different forms of biotechnology has enormous 
potential to impact human life and the natural environment. According to Persley 
(2003), genetic engineering, specifically genetic enhancement, has been adopted to 
achieve four main objectives: 
1.  Change product characteristics, e.g. make products more durable. 
2. Improve plant resistance to pests and pathogens. 
3. Enhance productivity of organisms. 
4. Increase nutritional value, e.g. Vitamin A content in foods. 
In short, the revolution related to biotechnology hold enormous potential in such areas 
as pharmaceuticals and agriculture. Consequently, the products of genetic engineering 
have unprecedented impact on agriculture, human health and the environment (Kyalo 
2008). It is with this in mind that advocates of genetically modified organisms view 
biotechnology as the panacea to the world’s most pressing challenges such as food 
insecurity, diseases, among others. This is particularly so in the Third World, which is 
most afflicted by these challenges. 
 
On the flip side, however, important concerns are rised about genetically modified 
foods that deserve serious interrogation. Johannes Tramper and Yang Zhu (2011) 
have posed the correct question: is modern biotechnology a panacea or the new 
Pandora’s Box? In the view of this article , the enormous potential that biotechnology 
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has on individuals, communities and the natural enviro ment makes it an issue of 
legitimate ethical concern. 
 
The GMO Debate in the Kenyan Context 
Kenya was ready to commence commercial farming of genetically modified crops 
following the finalization of biosafety guidelines that paved the way to the 
implementation of the Biosafety Act 2009. If the Act had been implemented, Kenya 
would have become the fourth country in Africa to engage in commercial farming of 
genetically modified organisms (GMOs). There are prsently only three African 
countries engaged in commercial GM farming, namely, South Africa, Egypt and 
Burkina-Faso (Adenle 2011). 
 
However, the debate surrounding the merits, demerits and other challenges of 
production and consumption of genetically modified foods in Kenya appears to be far 
from over. In fact it is set to gain even greater prominence in Kenya in particular and 
in the world as a whole. In the last four years, the media in Kenya has been replete 
with commentaries from many interest groups, including politicians, consumers and 
consumer organizations, and even the scientific community voicing either their 
support for or opposition to the introduction or importation of genetically modified 
products into the country. 
 
 The members of government in Kenya expected to imple ent the Biosafety Law 
have been equally divided in their opinion. For example, on July 24th 2011, the then 
Minister of Public Health and Sanitation, Hon. Beth Mugo, was quoted voicing strong 
objections to the country’s plan to import genetically modified maize to feed Kenyans 
who were threatened with starvation. The Minister’s a gument was simple and candid 
- the country lacked the capacity to test the suitabil y of genetically modified 
products (The Standard, 24th July, 2011, p.22). This, in our view, was not only a 
serious indictment, but at worst a negation of the whole process leading to and 
including the enactment of the Biosafety Act: the government was admitting 
incapacity to implement the Biosafety Act. 
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Potential Benefits of Genetically Modified Organisms 
It has already been noted in the foregoing section hat the revolution related to 
biotechnology holds enormous potential to impact such areas as agriculture, health 
and environment. In the area of human health, the benefits can be both direct and 
indirect. In a direct way, it has been documented that ransgenic animals (the products 
of genetic enhancement) have potential to serve as donors for organs, cells and tissues 
for transplants. Organ transplant is increasingly becoming an important option in 
health care. Indeed, it promises to solve some of the debilitating human health 
conditions. However, the area of transplant remains overly restrictive owing to the 
high cost involved world-wide (Boss 1999). Indirectly, genetic engineering can be 
utilized to produce crops with enhanced nutritional v ue. An example is the rice 
containing high level beta-carotene - a vitamin A precursor (Persley 2003). It is a well 
known fact that vitamin A deficiency is one of the leading causes of severe illnesses 
and child mortality (Goklany 2000). Further, due to their enhanced genetic capacity, 
transgenic animals can have increased performance in growth rate, carcass quality, 
milk production and disease resistance (Kyalo 2008). This way the products of 
genetically modified organisms would not only contribute to enhanced human health, 
but also to economic benefits. Further still, such technology can be utilized to remove 
or reduce allergens and toxicity from foods, or to increase antioxidant contents in 
food, among others (Persley 2003). In short, improved nutritional value of foods 
produced from GM technology will lead to improved human health and quality of life. 
 
In addition to benefits in human health, GM technology promises potential benefits to 
the natural environment. One of the greatest challenges of the 21st century is 
sustainable development that improves quality of both the natural environment and 
human life (WCED 1987). Biotechnology promises to contribute immensely to this 
area. For instance, through GM technology we can produce: 
1) Crops that can clean up the environment by absorption of various metals and 
metal complexes (Persley 2003). 
2) Crops that would reduce ground and surface water pollution (Goklany 2000). 
3)  Crops that are resistant to insect pests leading to less use of insecticides, and 
crops that absorb nitrogen and phosphorus at higher rat s thus reducing the 
amounts of chemical fertilizers in use (Kyalo 2008). 
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The quality of the natural environment is increasingly under threat due to factors such 
as high levels of emissions of greenhouse gases due to th  rise in human and industrial 
activities. Thus the application of biotechnology in the areas mentioned above will 
have a net effect of improved quality of the natural environment. It is also significant 
that enhanced soil fertility will lower the cost ofagricultural input and translate to 
increased food production. The problem of food insecurity in the Third World has 
been partly blamed on soils that have increasingly become infertile owing to 
excessive use of chemical fertilizers that have increased the level of alkalinity. The 
adoption of the GM technology would thus not only contribute to improved quality of 
the natural environment, but also to the efforts to mitigate the perennial problem of 
food shortage, particularly in the third world (Adenl  2011). Ultimately, however, the 
success of embracing GMOs will largely depend on the benefits obtained by the 
farmers in cultivating transgenic instead of conventional crops (Persely 2003). 
  
Potential Risks of Genetically Modified Organisms 
As we delve into this discussion, the question posed by Tramper and Zhu (2011) as to 
whether biotechnology is a panacea or the new Pandor ’s Box comes alive. To a very 
large extent, the controversy concerning whether or not to adopt GMOs revolves 
around the uncertainty regarding the safety of these products. The proponents of GM 
technology and products are strongly convinced thatere are no substantial risks 
beyond the normal risks engendered in conventional rganisms and foods. This is the 
most popular shade of opinion held mainly by researchers and scientists in the field of 
biotechnology, as well as by influential organizations involved not only in research 
but commercial farming and production of GMOs. The arguments on the benefits of 
GM technology discussed above validate this claim. For instance, The Royal Society 
National Academy of Science of the UK and the Commonwealth, one of the leading 
scientific organizations, in its endorsement of GMOs, avows that there is at present no 
evidence that GM foods cause allergic reactions. It goes on to assert that the risks 
posed by GM plants are in principle no greater than those posed by conventionally 
derived crops or by plants introduced from other parts of the world (cited in Newell 
and Glover 2003). 
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The unreserved stamp of approval by such influential organizations and scientists has 
greatly influenced the direction the GMO debate has taken the world over. It is also 
commonly argued by proponents of GMOs that there is no conclusive scientific 
evidence that GMOs have had deleterious effects on human health. While this may be 
the case, prudence cautions against falling into the trap of the fallacy of argumentum 
ad ignorantium (“appeal to ignorance”), that is, the argument thae fact that no one 
has so far proved conclusively that genetically modifie  foods have harmed humans 
does not of necessity mean that the opposite is true. Logically, lack of adequate 
evidence cannot be sufficient reason to warrant the conclusion that they are not 
harmful either now or in future. In any case, as shall be shown shortly, there is 
considerable amount of evidence to the effect that genetically modified foods have 
caused harm to other animals. The irony is that it is on the very basis of 
experimentation done on these same animals that the acclaimed safety and 
efficaciousness of genetically modified foods has been predicated and popularized. 
This means that if there is evidence of harm to anim ls, the potential of harm to 
humans is real. We can only conclude that the widespread fear of harm, either actual 
or potential, from consumption of genetically modified foods makes a compelling 
case for ethical concern. 
 
Uncertainty about the safety of GMOs remains of grave concern to all involved. A 
few examples suffice to illustrate this uncertainty. Charu Verma et. al. (2011) have 
argued that GMOs are inherently unsafe because GM technology presents unique 
dangers, namely, “the process itself creates unpredictable alterations irrespective of 
which gene is altered”. The uncertainty is real because even if actual evidence of 
maleficence has not been demonstrated, both the hazards and benefits of GM foods 
remain difficult to predict and measure accurately, and more so particularly if we take 
a long term view. This is partly explainable, on the one hand, within the framework 
that more organisms and crops continue to be developed with novel characteristics. 
On the other hand we have to deal with the complexity of genetic codes and 
ecological and social systems in which genetically engineered crops are produced and 
used. This is in our considered opinion of significant ethical concern, and forms a 
basic premise upon which key arguments in this article are articulated in the coming 
sections. 
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Furthermore, there are reported cases of harm arising from consumption of GM foods. 
One compelling case is in an elaborate report of 1989, clearly documenting actual 
hazards of GM foods. In this case it was reported that more than 5000 people who had 
eaten high doses of L-tryptophan – a dietary supplement, presented conditions such as 
insomnia and depression, developed Eosinhilia Myaglia Syndrome (EMS), an illness 
characterized by painful and swollen muscles, rashes, gastro intestinal problems and 
huge numbers of white blood cells. The case was traced to L-tryptophan food 
supplement produced by Showa Denko KK using GM bacteria. It was noted that the 
new toxin had never been found in the conventional version of the product 
(Kilbourne, Philen, Kamb and Falk 1996). 
 
There is also documented evidence that transgenic mice can have multiple gene 
insertions, higher mutation rates and greater propensity to cancer than their normally 
generated counterparts (Orian et. al. 1990). Additionally, the possibility of GMOs 
raising health concerns, for example by being respon ible for the emergence of new 
diseases is very well envisaged. For example, Robert Anderson, a scientist in genetics, 
environmental issues and peace and social justice who had worked for long with 
Physicians and Scientists for Responsible Genetics in New Zealand, was quoted in the 
media unequivocally stating: 
Genes, like viruses can affect the body which should warn of the 
potential risks of transgenic organisms as a reservoir for new diseases 
and as a medium for the evolution of new pathogens because of their 
altered physiology and biochemistry (The Sunday Standard, 14th 
October, 2007). 
 
It is quite feasible that genes transferred from foods to which people are allergic may 
trigger allergic reactions in consumers of these products. This is because through 
genetic engineering, allergens can be transferred from conventional foods into GM 
foods and vice versa (FAO 2001). It is also a real possibility that with a new 
biochemistry, genetically modified organisms may pose direct health concerns to the 
consumers. Indeed, “adding new genetic materials into some plants may reactivate 
pathways to toxicity or otherwise increase levels of toxic substances within plants” 
(Barret and Flora 2000). It is also envisaged that rans-genesis may alter nutritional 
value of foods in unpredictable ways. One possible outcome of this could be excess 
nutrients that may negatively affect some categories of consumers such as the elderly, 
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pregnant women and infants (Lappe 1999). In addition, the possibility of accelerated 
problems of antibiotic resistance may result in an increase in antibiotic resistance 
diseases, thus posing serious challenges in the health s ctor (FAO 2001). 
 
We have already argued in the section on benefits of biotechnology that apart from 
enriching human life in many ways, the biotechnological revolution also promises to 
reduce the human footprint on the natural environment. Be that as it may, however, 
real and/or potential risks posed by genetic modification to the natural environment 
are well documented. Such risks have been identified by the World Health 
Organization (WHO) as: risks on non target organisms, effects on biodiversity, 
invasiveness and development of resistance (WHO 2005). 
 
On the hazards of GM crops on the environment and bio iversity, it is reported that in 
a laboratory test carried out in the US, it was demonstrated that the pollen from GM 
maize damaged the caterpillars of the monarch butterfly (Batalion 2000). 
Additionally, in commercial farming and production, there is the real possibility of 
cross- breeding between GM crops and the surrounding co ventional vegetation. The 
novel characteristics of the GM crops, which may include resistance to insects and 
herbicide tolerance, may be passed on to these plants, with the devastating effects of 
creating super weeds - that will eventually require increased use of herbicides (Barret 
and Flora 2000). This would then be counterproductive, as it would effectively nullify 
any gains envisaged in reduced use of herbicides as an environmental benefit of 
GMOs. It is with the foregoing in mind that we evalu te the ethical objections to 
GMOs in Kenya. 
 
Ethical Concerns about GMOs in Kenya 
The foregoing discussion reveals that in GMOs we se a convergence of 
anthropocentric, biocentric and ecocentric concerns, as any changes brought about by 
these organisms will affect humans, other living oranisms and the ecosystem as a 
whole. Ethics as a normative philosophical inquiry is relevant in this context to help 
us articulate the value dimension of the issues related to the effects of GM technology 
and products. One of the central questions of normative ethics is “What makes actions 
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right or wrong?” Put differently, ethics asks: “Why ought moral agents to do certain 
things and not others?” 
 
In this section we discuss some of the ethical objections raised against the process that 
led to legislation about the production and consumption of GMOs in Kenya. We 
proceed from the premise that all technological innovations raise a plethora of ethical 
concerns, challenges and even dilemmas. Presently there is a palpable resistance to 
production and consumption of GM foods around the world. However, it is not the 
purpose of this article to put forward moral arguments for the outright rejection of 
biotechnology per se. This is essentially because any technological innovation, 
biotechnology included, is part of human striving, and we cannot stop humans from 
venturing into new areas of knowledge. Thus the old argument by a few conservative 
opponents that genetic engineering is unnatural commits the naturalistic fallacy. The 
very obligation to satisfy the human right to knowledge is itself adequate justification 
for research in biotechnology. Technology as a dynamic human striving is, in the 
words of Hilhorst (1994), “not neutral but purposeful”. This makes the embracing of 
any technology a legitimate subject of normative asses ment. 
 
In normative ethical theory, the easiest way to justify GMOs is from a 
consequentialist perspective. The utilitarian theory, for instance, focuses on the end 
result of actions or processes to determine their rightness or wrongness. Thus it is very 
close to common sense reasoning. Consequently, utilitarianism is a potent tool for 
assessing the actual impact of the GM technology. From the reflections in the 
preceding sections, it is clear that sufficient considerations exist to justify adoption of 
GMOs on consequentialist grounds. In an earlier section the actual and potential 
benefits of GMOs were enunciated, and they provide consequentialist justification for 
GMOs. 
 
The principle of beneficence could also easily be invoked to justify GMOs. This 
principle requires that we act so as to promote the welfare of others ( Shannon 1993). 
If one of the main arguments for GMOs, particularly in the Third World, is to 
alleviate food insecurity and therefore promote overall human well-being, GMOs 
would find sufficient justification within the duty of beneficence. Indeed, GMOs 
would afford those who suffer the debilitating effects of perennial food shortages a 
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fair opportunity to realize their well-being. Making a case for adoption of 
biotechnology in Africa, Adenle (2011) has enunciated the economic and other 
benefits gained from biotechnology by the four African countries that have embraced 
it. 
 
However, considering that research and technological advancement ought to be 
channeled towards promoting the greater good of humanity and that of the natural 
environment, an interrogation of the ethical response to the challenges posed by 
widespread use of GM foods is in order. In so far as ethics in relation to GMOs is 
concerned, we pose with Hilhorst (1994) four pertinnt questions: 
1) When do people cause harm to themselves, and are they justified to do so?  
2) When do people act at the expense of other people, present, past and future 
generations and the natural environment?  
3) When are people justified to make fundamental decisions on behalf of others? 
4)  At the cost of whom and what has technology been pursued? 
 
 This article does not pretend to answer these questions definitively, but attempts to 
shed some light on some key ethical concerns in the GMO debate. To do this we shall 
restrict ourselves to some fundamental ethical principles that provide useful 
guidelines in debating normative issues. 
 
The Principle of Informed Consent 
The principle of informed consent is important in decision making, and therefore 
serves a critical role in ethics. Generally, when one consents to something, he/she 
assumes not only control but also responsibility for his or her actions. Thus consent 
protects autonomy and self- determination, and ensur s that people are not easily 
manipulated, deceived and exploited. In the context of the debate as to whether or not 
to adopt the use of genetically modified crops, it provides a platform to discuss the 
value implications of the technology and the process l ading to its adoption. 
 
Shannon (1993) identifies four main criteria by which to determine whether or not 
consent is genuine, namely, competence, disclosure, comprehension and 
voluntariness. Competence refers to the mental capability of a person to make a 
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reasonable decision. This is the prerequisite for consent. It emphasizes the inextricable 
link between being rational and moral in decision making. 
 
Disclosure refers to the actual information that is provided to the person(s) whose 
consent is being sought. It is critical to the facilitation of consent, as it delves into the 
substance or content which is the subject of the consent negotiation. It affirms the 
adage that “information is power”. Information thus empowers a person to decide 
whether or not to consent. 
 
Comprehension is the ability to make sense of the information. It is one thing to have 
information, but quite another to make sense of it and to benefit from it. Thus 
comprehension ensures that the recipient of the information is able to utilize it to 
make a reasonable choice. 
 
Finally, voluntariness refers to being in a position to make a choice that is not 
predetermined by the party seeking the consent. It means being in a position to make a 
free choice. Voluntariness therefore not only assure  an individual the freedom of 
choice, but also enhances ownership of the said choices. Voluntariness helps to 
eliminate two major impediments to free choice, namely, undue influence and 
coercion (Shannon 1993). 
 
Thus the pertinent question pursued in this article is: can the widespread adoption of 
GMOs, as envisaged in Kenya, satisfy the stringent criteria of informed consent to the 
would be consumers as outlined above? 
 
In Kenya, we see one major objection to the adoption of GMOs arising from 
challenges of informed consent. To satisfy the requi ment of informed consent on the 
standard of disclosure, the information disclosed must be relevant, accurate and 
sufficient. In the case of genetically modified crops and foods, the criterion of 
disclosure would be satisfied if and only if the actu l or potential benefits and hazards 
are clearly disclosed to the prospective consumers. Furthermore, because of the likely 
widespread impact of GMOs, consent would be genuine o ly if communities are 
sufficiently consulted to create public awareness and cceptance. 
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Moreover, in Kenya as in many other Third World countries, studies have regrettably 
shown that public participation in debate on GMOs ha not been adequately done. For 
example a study on stakeholders’ participation in biotechnology policy formulation in 
Kenya by Kyalo (2008) showed that only 20% of the identified stakeholders 
participated. These findings are corroborated by studies in other countries. Thus the 
main predicament is that public participation is very low, and yet there exist many 
complexities and dynamics regarding GM foods that my come into conflict with the 
values of the potential consumers (Kyalo 2008). 
 
The uncertainties surrounding GM crops and foods, some of which have been 
discussed in an earlier section of this article, provide a compelling argument for the 
need to attain the highest threshold of disclosure. Yet this threshold has not been met 
in Kenya. Consequently, any purported consent that w s sought from Kenyan 
consumers before the enactment of the relevant law w s not genuine. This failure to 
adequately involve critical stakeholders and the general public may undermine the 
Cartagena Protocol on biosafety. The Cartagena Protocol provides in Article 23 
(SCBD 200) that parties shall: 
a) Promote and facilitate public awareness, education and participation 
concerning safety, transfer, handling and use of living modified organisms in 
relation to the conservation and sustainable use of biological diversity taking 
into account risks to human health; 
b) Endeavour to ensure that public awareness and education encompasses access 
to information on living modified organisms. 
 
Without accurate, relevant and sufficient information, the adoption of GMOs may 
expose the consumers to serious risks that they would have avoided had they stuck to 
the conventionally bred crops. Failure to fulfill the outlined criteria of informed 
consent greatly compromises the genuineness of consent. We share the commonly 
held wisdom that cautions responsible restraint and suspended action in a situation of 
ignorance about indirect or delayed consequences of any technology, particularly 
when the envisaged effects or consequences may be harmful and/or irreversible. This 
is particularly crucial to the Third World countries whose “limited capacity to cope 
with the manner and scale of known and potential risks associated with living 
modified organisms” is well acknowledged (SCBD 2000). 
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In the case of GMOs, the Cartagena Protocol on Biosafety (SCBD 2000) had already 
acknowledged the potential safety risks involved anrecommended the precautionary 
principle as had been proposed by the Conference of the State Parties to the 
Convention on Biological Diversity. The precautionary principle essentially requires 
delayed decision making, in order to take due care in anticipating unforeseen negative 
implications of a withheld decision. The scientific uncertainty of GMOs as 
demonstrated in earlier pages of this article is sufficient reason to warrant the 
application of the precautionary principle. 
 
 In Kenya, the inadequate scientific capacity to evaluate GM products was 
acknowledged by the then Ministry of Public Health and Sanitation, and also by the 
Kenya Plant Health and Inspectorate Services (KEPHIS) (Sunday Standard 4th July, 
2011). This acknowledgement makes the case for the application of the precautionary 
principle even more ethically compelling. In addition, Kenya, being a signatory to the 
Cartagena Protocol, is legally obligated to uphold this principle. Thus while GM crops 
and foods promise greater relief in mitigating the problem of food insecurity, in the 
light of uncertainties related to the GM technology, the precautionary principle 
remains a reasonable ethical guide in decision making. 
 
Kenya may still fall short of satisfying other criteria of informed consent, particularly 
voluntariness, which, as noted above, is satisfied only when a choice made is free 
from any form of manipulation, coercion or undue influence. As argued in the 
preceding pages, both inadequate standards of disclosure and comprehension severely 
restrict the voluntariness of the action, and thus render any consent a nullity. 
However, the more pertinent question is: are Third World countries in a position to 
consent genuinely in the case of GMOs? The asymmetrical structural relations that 
exist between the materially wealthy countries of the north and the Third World 
countries render the latter countries politically, economically and scientifically too 
weak to resist exploitation and manipulation by themultinationals that control the 
GMO research and industry. 
 
The foregoing argument is succinctly articulated by Nvindi - a member of the Kenya 
Biodiversity Coalition (KBioC) - who was quoted in the media as stating that “for the 
Ethical Objections to Genetically Modified Foods in Kenya 67 
 
poor nations, whether or not to adopt genetically modified products is hardly an 
objective decision for governments and farmers. Rather, it is presented as take-it-or-
perish prescription. The argument goes that, by planting high-yielding GMOs 
contrasted to the traditional variety, food sufficiency would be guaranteed” (The 
Standard, 5th  May, 2011). Commenting specifically on the debate between the pro-
GMO group (spearheaded mainly by the multinational companies) and the advocates 
of conventional agriculture, preceding the passing of the Biosafety Law in Kenya, 
Nvindi observed that “it was apparent genuine debate on the merits and demerits of 
the GMOs had been subverted by powerful, vested intres s”. 
 
It is apparent that poor countries and farmers often ind themselves in vulnerable 
situations that severely restrict their genuine fredom to make informed and voluntary 
decisions, thereby rendering them incapable of genuin  informed consent. Yet 
exploiting and manipulating the uniquely weak situations of Third World countries to 
make them embrace GMOs simply amounts to a violation of the moral duty to refrain 
from exploiting the vulnerable. 
  
The Principle of Respect of Persons 
The principle of respect of persons is predicated on the intrinsic value of persons 
which is rooted in their humanity. Emmanuel Kant captures the essence of this aptly 
when he argues that moral imperatives require of moral agents to respect the dignity, 
integrity and value of persons as ends and not as mere eans (Kant 1952). According 
to Shannon (1993), the principle of respect of persons requires of moral agents two 
important ethical duties. 
 
First, there is the duty to treat persons as autonom us agents. This essentially means 
recognizing individuals’ right to self -determination. In other words, the principle lays 
an obligation on moral agents to respect a person’s freedom to choose what should 
happen to him/her and what should not happen to him/her. It further requires that we 
respect the individual’s decisions to the extent that they are competent. This 
opportunity is afforded only when adequate standards of informed consent as 
discussed in the preceding section are satisfied. 
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The second requirement of the principle of respect of persons is the duty to protect 
persons with diminished autonomy. This is premised on the recognition that not all 
persons and communities can be autonomous: some interve ing factors may 
compromise their capacity for autonomy. To the extent that capacity for acting 
autonomously is impeded, the principle of respect of persons requires that such 
persons and communities be protected from possible harm, fraud, deception, 
exploitation and manipulation. It is a standard ethical requirement that such persons 
and communities be guided about the likely consequences of their actions. 
 
In Kenya, because of the inability to sufficiently meet the requirements of informed 
consent, the process leading to legal adoption of GMOs may also fall short of the 
ethical requirements of the principle of respect of persons on both standards outlined 
above. The principle of respect of persons would requir  that even if we are motivated 
by a noble desire to alleviate the suffering caused by hunger, if harm may be 
occasioned by the means used to achieve that end, we must re-evaluate the options. 
This principle, in our view, remains a reasonable guide in the case of the decision to 
adopt or not adopt GMOs, particularly in Third World countries. As shown earlier on 
in this article, there are real and potential harms of GMOs. This means that the GM 
technology ought to be subjected to the highest standards of the requirements of the 
principle of respect of persons. In the same breath, the principle of respect of persons 
may also require sensitivity to the socio-cultural, ethical, and religious values and 
sensibilities of the consumer communities. It is well noted with concern that the 
adoption of GM crops and foods may offend certain ethical, socio- cultural and 
religious values and sensitivities of some communities. A case in point is the use of 
transgenic organisms (the mixing of genes in organisms across species) for food and 
as organs for transplant. Such measures may seriously up et cultural and religious 
values on dietary requirements by some communities. For instance, organisms that 
may contain the genetic material of pigs would be highly offensive to Muslim and 
Jewish communities who regard pigs as unclean. One may counter this view by 
arguing that sufficient labeling of GM crops and foods will adequately protect 
consumer choice and autonomy. This argument, though valid, is operationally not 
feasible if contextualized, particularly within Third World countries with feeble 
capacities to monitor compliance. Indeed, it is genuinely feared that a lot of unlabeled 
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or mislabeled GM products will or have already found their way into the Kenyan 
market unnoticed in spite of the ban imposed by government. 
 
Furthermore, it is still plausible to argue that even if proper labeling is done, the 
question of whether the vulnerable populations have genuine choice remains real and 
of legitimate ethical concern. Two arguments suffice to support this view. First, as 
earlier observed, no adequate education and participation has been facilitated to raise 
the requisite awareness for informed choice. The majority of the consumers therefore 
remain largely unaware of the risks of GMOs. Second, with the widespread adoption 
of GM technology, the conventionally produced foods are likely to be more expensive 
than the GM foods. The cost per se would therefore deny the poor members of the 
population genuine choice. 
 
Inter-generational and Inter-species Justice 
The principle of inter-generational justice is predicated on the assumption that future 
generations have rights which may be jeopardized by the choices and actions of the 
present generation. As already pointed out, real concerns exist about the potential 
hazards of GMOs, many of which may have long term consequences that remain 
largely unknown. In the light of this, a pertinent ethical question is: to what extent can 
the present generation justifiably assume risks on behalf of future generations? (Smith 
1997). 
 
Furthermore, GM technology is evolving, so that its real impact may not be felt in the 
present. As such, the unknown and unforeseen consequences of GMOs may affect 
future generations on a larger scale than they may the present generation. In addition, 
due to the uncertainties that surround GMOs, it may warrant experimentation on 
humans for humanity to get to know their real impact. In fact, it may well be the case 
that those already consuming GM products are unknowingly playing guinea pigs in 
the experimentation without their informed consent. Most importantly, the effects 
may take a long time to be felt by future generations. This would be an indictment on 
the present generation for the serious violation of the fundamental rights of the 
affected members of future generations. 
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In response to the foregoing concern, proponents of GM technology may invoke the 
principles of proxy consent and double effect. 
 
While proxy consent may be relied upon to make critical decisions on behalf of others 
who for some reason may not be able to make decisions on their own, the 
uncertainties surrounding the GMOs raise concerns about the applicability of this 
principle in this context (Wrigley 2007). In ethical theory, proxy consent traditionally 
offers little guidance on assuming responsibility on behalf of future persons. In the 
case of GMOs, given that their real impact may be on future generations rather than 
on the present one, the threshold of assuming risks on their behalf must be high. 
 
The principle of double-effect may also be invoked to justify some actions that may 
have deleterious consequences on others. It is helpful in evaluating the moral 
justifiability of certain harms and risks in some situations. The principle, sometimes 
known as situation ethics, provides that “an act which is otherwise ethically 
objectionable may be morally acceptable if it is the inevitable and unavoidable 
consequence of carrying out a primarily morally desirable intervention” (Shannon 
1993, 130). According to Shannon (1993, 6), the principle of double effect must 
satisfy the following four conditions: 
1) What we are going to do must not be evil or wrong. 
2) The harm we are considering must not be the means of producing the good 
effect. 
3) The evil or harmful effect may not be intended, butmerely permitted and 
tolerated. 
4) There must be proportionate reason for performing the action in spite of the 
consequences the act has. 
 
The principle of double effect is a valid ethical guide to calculating the risks and 
harms related to the adoption of some GM foods. However, if the GM technology 
causes changes that are irreversible, then on the basis of the criteria outlined above, 
we cannot rely on this principle to justify such intervention. 
 
Further, Barrett and Flora (2000 ) noted that widespr ad genetic modification may 
have a negative impact on the natural environment in such ways as environmental 
degradation, irreversible damage to the environment, modification of species, the 
undermining of biodiversity, among others. These possibilities further raise 
fundamental concerns that may render the adoption of GMOs ethically objectionable. 
In the light of emerging biocentric and ecocentric ethical sensitivities regarding the 
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natural environment, Hilhorst (1994) raises four questions that are pertinent to this 
debate: 
1. What are the limits of human control of genetic destiny? 
2. To what extent are humans justified to live at the expense of the natural 
environment? 
3. To what extent can we justify the exercise of the human ability to create new 
forms of life, e.g. animals? 
4. If animals have rights, can we justify cloning and engineering them purely as 
means to human ends? 
These and other questions raise legitimate concerns about the integrity of species and 
the value of other beings such as wild animals. For example, animal rights ethicists 
strongly believe that animals have intrinsic value that ought to be recognized and 
respected by human moral agents. Thus any technology that treats animals as mere 
means for human purposes severely violates the morality predicated on biocentric and 
ecocentric arguments. It is not within the scope of this article to venture into the 
controversies of animal rights ethics, but the welfar  of animals and that of the natural 
environment is of legitimate ethical concern. The net effect of widespread adoption of 
genetic engineering and transgenesis is the inevitable nd widespread comodification 
of animals. This comodification may undermine the integrity and sustainability of the 
biotic community. 
 
A more pertinent concern in the GMO debate is the possible inclusion of human 
genetic material into other animal species and viceersa. This, as alluded to in the 
preceding pages, not only raises the question of the integrity of species, but obviously 
upsets dietary sensibilities and concerns among many communities. Most importantly, 
it raises fundamental concerns about the question of keeping genetic boundaries 
among species. These are pertinent ethical concerns, but they cannot be sufficiently 
dealt with in this article . 
 
The Principle of Non-maleficence 
The principle of non-maleficence stipulates that moral agents have a duty not to cause 
harm to people (Shannon 1993, 7-8). Thus it presupposes the principle of beneficence, 
which is a positive duty requiring moral agents to contribute to the well-being of 
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others. Non-maleficence is a negative moral duty which obligates persons to refrain 
from causing harm. The principle is based on the simple reasoning that if we can not 
benefit others, probably because we do not have the capacity to do so, at least we 
ought not to cause them harm. The principle also inc rporates the duty not to expose 
people to the risk of harm. 
 
In the context of the GMO debate, the principle of n n-maleficence would require that 
if we cannot help to solve the problem of food insecurity for the poor, at least we have 
a duty to refrain from causing them further harm. To the extent that GMOs may 
expose consumers to the risk of harm that is beyond the risk to which they are 
exposed through consumption of foods from conventional crops, unless the harm is 
unavoidable, those who put in place policies that allow and encourage the use of 
GMOs violate the principle of non-maleficence. The same obligation that we owe 
fellow human beings not to cause them harm when we can avoid doing so can extend 
to the natural environment. McFague (1993) has advanced a similar line of thought by 
asserting that nature is the “new poor”, and hence deserves the special obligation that 
human beings owe to poor and oppressed fellow humans. 
 
The Legal Framework for GMOs in Kenya: An Evaluation  
The Conference of the State Parties to the Convention on Biological Diversity, at its 
second meeting held in November 1995, established an Ad Hoc working group to 
develop a draft protocol, known as the Cartagena Protocol on Biosafety to the 
convention on biological Diversity (SCBD1995). It was adopted by the conference of 
state parties on 29th January, 2000, and came into force in 2003. It provides an 
international regulatory framework to ensure biosafety among the state parties. Kenya 
signed the Cartagena Protocol in 2000, and subsequently ratified it in 2003, way 
before the enactment of its own laws on Biosafety. 
 
The journey to the creation of a legal framework to regulate biotechnology in Kenya 
was long and controversial. The search culminated in the signing of the Biosafety Act 
in 2009. The Act created the National Bio-safety Authority to operationalize it. It is 
commendable that the membership to this Authority is broad based, including 
significant stakeholders such as farmers, consumers, experts in biotechnology, law, 
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among others. The Authority commits itself in its objectives, inter alia, to ensure the 
safety of human and animal health, and to promote the protection of the natural 
environment. To achieve these goals, the Authority has, among others, the following 
two key objectives: 
1) To promote awareness and education among the general public in matters 
relating to biosafety. 
2) To provide the legal framework to mitigate the potential risks arising from 
biotechnology and protect the consumers, environment etc. 
These objectives are in tandem with the Cartagena Protocol on Biosafety. They are 
crucial because they reflect the reality that biotechnology affects people, both 
positively and negatively, so that the law is a major instrument to mitigate any 
challenges that may arise. 
 
It is not within the scope of this article to interrogate the Biosafety Act and the 
National Biosafety Authority. However, of great interest to this article are the 
questions: is the enactment of the law a panacea to the challenges arising from 
biotechnology? Does it effectively mitigate the conerns about inadequate public 
awareness, participation and education in biotechnology, and specifically public 
concerns about GMOs? In response to these concerns, two issues merit a brief 
discussion. 
 
The first issue concerns the process leading to the enactment of the Biosafety Act. 
Studies show that public participation by various stakeholders was not adequate in the 
run-up to the writing of the act. For instance, a study by Kyalo (2008) showed that 
significant segments of society, including University lecturers, Scientists, Industry 
players, NGOs and other stakeholders reported low levels of participation in the 
drafting of the Biosafety Bill. This was a violation of Article 23 of the Cartagena 
Protocol on public participation as cited in an earli r section of this article. The net 
effect of this is that the majority of Kenyans, including the elites in Academia and 
industry, as well as the general public, remain largely unaware of the potential 
benefits and risks of biotechnology. The attitude and actions of the Kenyan 
government after the enactment of the law lends credence to this view. The 
government has been reluctant to allow the importati n and commercial farming of 
GM crops, even after putting in place the requisite legal framework and guidelines. 
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This reluctance, in our view, not only betrays the government’s lack of confidence in 
the legal instruments and its other capacities to guide biotechnology, but also its fear 
of a backlash owing to the low levels of public awareness about genetically modified 
crops and biotechnology in general. 
 
Secondly, the enactment of the Biosafety Act, the creation of the National Biosafety 
Authority, and the finalization of the biosafety guidelines have not helped matters. 
The Authority, whose foremost objective, as noted a little earlier, is to promote public 
awareness and education on matters relating to biosafety, has not done much in this 
regard. This failure has denied the country the opportunity to build public confidence 
in biotechnology in general, and in GM foods in particular. In short, the ethical 
concerns and challenges raised earlier on in this art cle have not been sufficiently 




There is no doubt that biotechnology and related technologies hold enormous 
potential in the fields of pharmaceuticals, medical re, agriculture and other areas. 
This in turn has unprecedented potential impact on human health and the natural 
environment. It is also not in doubt that GM technology promises novel responses to 
the perennial problem of food deficit, particularly in the third world. This 
notwithstanding, there are also legitimate concerns of possible risks associated with 
GM foods that may exceed those posed by conventionally produced foods. 
 
This article has argued that like all other technological innovations, biotechnology is a 
human striving which cannot be stopped, but rather ought to be encouraged. It 
however raises fundamental ethical questions, challenges and even dilemmas that 
must be candidly confronted. It is only through such engagement that we can deploy 
such technological advancements to the service of the greater anthropogenic, 
biocentric and ecocentric good. 
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